JP2007502101A5 - - Google Patents

Download PDF

Info

Publication number
JP2007502101A5
JP2007502101A5 JP2006521226A JP2006521226A JP2007502101A5 JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5 JP 2006521226 A JP2006521226 A JP 2006521226A JP 2006521226 A JP2006521226 A JP 2006521226A JP 2007502101 A5 JP2007502101 A5 JP 2007502101A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
acid sequence
amino acid
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006521226A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007502101A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/023523 external-priority patent/WO2005009379A2/en
Publication of JP2007502101A publication Critical patent/JP2007502101A/ja
Publication of JP2007502101A5 publication Critical patent/JP2007502101A5/ja
Pending legal-status Critical Current

Links

JP2006521226A 2003-07-24 2004-07-22 スタフィロコッカス・アウレウスに対して防御免疫応答を誘導するポリペプチド Pending JP2007502101A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48984003P 2003-07-24 2003-07-24
US52011503P 2003-11-14 2003-11-14
PCT/US2004/023523 WO2005009379A2 (en) 2003-07-24 2004-07-22 Polypeptides for inducing a protective immune response against staphylococcus aureus

Publications (2)

Publication Number Publication Date
JP2007502101A JP2007502101A (ja) 2007-02-08
JP2007502101A5 true JP2007502101A5 (cg-RX-API-DMAC7.html) 2007-05-24

Family

ID=34107815

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521226A Pending JP2007502101A (ja) 2003-07-24 2004-07-22 スタフィロコッカス・アウレウスに対して防御免疫応答を誘導するポリペプチド

Country Status (23)

Country Link
US (2) US20060177462A1 (cg-RX-API-DMAC7.html)
EP (1) EP1651166B8 (cg-RX-API-DMAC7.html)
JP (1) JP2007502101A (cg-RX-API-DMAC7.html)
KR (1) KR20060065643A (cg-RX-API-DMAC7.html)
AT (1) ATE457737T1 (cg-RX-API-DMAC7.html)
AU (1) AU2004258979B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0412799A (cg-RX-API-DMAC7.html)
CA (1) CA2532370A1 (cg-RX-API-DMAC7.html)
CY (1) CY1110028T1 (cg-RX-API-DMAC7.html)
DE (1) DE602004025579D1 (cg-RX-API-DMAC7.html)
DK (1) DK1651166T3 (cg-RX-API-DMAC7.html)
ES (1) ES2342778T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20100240T1 (cg-RX-API-DMAC7.html)
IL (1) IL173253A0 (cg-RX-API-DMAC7.html)
IS (1) IS8213A (cg-RX-API-DMAC7.html)
MX (1) MXPA06000854A (cg-RX-API-DMAC7.html)
NO (1) NO20060898L (cg-RX-API-DMAC7.html)
NZ (2) NZ570750A (cg-RX-API-DMAC7.html)
PL (1) PL1651166T3 (cg-RX-API-DMAC7.html)
PT (1) PT1651166E (cg-RX-API-DMAC7.html)
RU (1) RU2337108C2 (cg-RX-API-DMAC7.html)
SI (1) SI1651166T1 (cg-RX-API-DMAC7.html)
WO (1) WO2005009379A2 (cg-RX-API-DMAC7.html)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410798B (de) 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
US20070134263A1 (en) * 2004-02-18 2007-06-14 Anderson Annaliesa S Polypeptides for inducing a protective immune response against staphyloococcus aureus
AU2005310981A1 (en) * 2004-10-25 2006-06-08 The University Of Western Ontario Vaccines, compositions and methods based on Staphylococcus aureus iron-regulated surface determinants IsdA, IsdB, and IsdC
GB0526038D0 (en) * 2005-12-21 2006-02-01 Glaxosmithkline Biolog Sa Immunogenic composition
CA2637152A1 (en) * 2006-01-27 2007-08-09 Merck & Co., Inc. Antigen-binding proteins targeting s. aureus orf0657n
AU2008251982A1 (en) 2007-01-24 2008-11-20 Merck Sharp & Dohme Corp. Polypeptides for inducing a protective immune response against Staphylococcus epidermidis
EP2374467B1 (en) * 2007-05-04 2013-08-28 Martin Krönke Protective staphylococcus aureus vaccine based on cell wall-associated proteins
WO2009029132A2 (en) 2007-05-31 2009-03-05 Merck & Co., Inc. Antigen-binding proteins targeting s. aureus orf0657n
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
JP5658564B2 (ja) 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
WO2010014304A1 (en) 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
EP2376111A4 (en) 2008-11-26 2013-01-09 Merck Sharp & Dohme POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS
HUE026855T2 (en) 2009-04-03 2016-07-28 Univ Chicago Compositions and methods related to protein a (spa) variants
EP3263128A3 (en) 2009-04-14 2018-01-24 GlaxoSmithKline Biologicals S.A. Compositions for immunising against staphylococcus aureus
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
BR112012009014B8 (pt) 2009-09-30 2022-10-04 Novartis Ag Processo para preparar conjugado de polissacarídeo capsular de s. aureus tipo 5 ou tipo 8 e molécula de transporte crm197, conjugado e composição imunogênica
HUE034251T2 (en) 2009-10-30 2018-02-28 Glaxosmithkline Biologicals Sa Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
GB0919690D0 (en) 2009-11-10 2009-12-23 Guy S And St Thomas S Nhs Foun compositions for immunising against staphylococcus aureus
EP2544709A4 (en) * 2010-03-12 2014-01-08 Univ Pennsylvania METHOD FOR PREVENTING AND TREATING THE COLONIZATION OF STAPHYLOCOCCUS AUREUS AND THEIR INFECTIOUS DISEASES AND DISEASES
CA2803298C (en) 2010-07-02 2020-07-14 The University Of Chicago Compositions and methods related to protein a (spa) variants
WO2012021229A1 (en) 2010-07-13 2012-02-16 Merck Sharp & Dohme Corp. Staphylococcus aureus surface protein sa1789 and protective vaccine based thereon
EP2638058B1 (en) 2010-11-12 2017-01-11 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
RU2014112343A (ru) 2011-09-01 2015-10-10 Новартис Аг Оставы антигенов staphylococcus aureus, содержащие адъюванты
US9527892B2 (en) 2011-10-31 2016-12-27 Merck Sharp & Dohme Corp. Protective vaccine based on Staphylococcus aureus SA2451 protein
RU2639287C2 (ru) * 2012-06-27 2017-12-20 Ф. Хоффманн-Ля Рош Аг Способ отбора и получения высокоселективных и мультиспецифичных нацеливающих групп с заданными свойствами, включающих по меньшей мере две различные связывающие группировки, и их применения
KR20150030744A (ko) 2012-06-27 2015-03-20 에프. 호프만-라 로슈 아게 표적에 특이적으로 결합하는 하나 이상의 결합 단위를 포함하는 항체 Ｆｃ－영역 접합체의 제조 방법 및 그의 용도
US9376487B2 (en) 2012-07-10 2016-06-28 Merck Sharp & Dohme Corp. Protective vaccine based on Staphylococcus aureus SA2493 protein
US10738338B2 (en) 2016-10-18 2020-08-11 The Research Foundation for the State University Method and composition for biocatalytic protein-oligonucleotide conjugation and protein-oligonucleotide conjugate
US12514914B2 (en) 2019-05-14 2026-01-06 The University Of Chicago Methods and compositions comprising Staphylococcus protein a (SpA) variants
CN114929750B (zh) 2019-09-13 2024-11-22 芝加哥大学 用于治疗葡萄球菌感染的方法和组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
WO2000071585A1 (en) * 1999-05-03 2000-11-30 Medarex, Inc. Human antibodies to staphylococcus aureus
GB0014907D0 (en) * 2000-06-20 2000-08-09 Univ Sheffield Antigenic polypeptides
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
MXPA03011701A (es) * 2001-06-15 2004-12-06 Nhibitex Inc Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus.
CN101979413A (zh) * 2001-11-12 2011-02-23 诺沃挪第克公司 通过金属离子亲和层析法的肽纯化
WO2003053462A2 (en) * 2001-12-11 2003-07-03 Merck & Co., Inc. Staphylococcus aureus exopolysaccharide and process
US20080050361A1 (en) * 2004-10-25 2008-02-28 Heinrichs David E Staphylococcus aureas specific anti-infectives
AU2007281934B2 (en) * 2006-01-18 2012-11-15 University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins

Similar Documents

Publication Publication Date Title
JP2007502101A5 (cg-RX-API-DMAC7.html)
RU2006105498A (ru) Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus
CN114634556B (zh) 一种新冠病毒Delta和Omicron变异株嵌合抗原、其制备方法和应用
Lecordier et al. Characterization of a dense granule antigen of Toxoplasma gondii (GRA6) associated to the network of the parasitophorous vacuole
JP2008529558A5 (cg-RX-API-DMAC7.html)
JP2002537791A5 (cg-RX-API-DMAC7.html)
JP2002510494A5 (cg-RX-API-DMAC7.html)
JP2006516189A5 (cg-RX-API-DMAC7.html)
JPH09322781A5 (cg-RX-API-DMAC7.html)
JP2002542827A5 (cg-RX-API-DMAC7.html)
JP2008538183A5 (cg-RX-API-DMAC7.html)
JP2002531129A5 (cg-RX-API-DMAC7.html)
CN116041448B (zh) 新型冠状病毒免疫原性物质、其制备方法和应用
CA2385325A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
RU2011122615A (ru) Живой аттенуированный респираторно-синцитиальный вирус
CN117050193B (zh) 一种β冠状病毒重组嵌合抗原、其制备方法及应用
WO1993020844A1 (en) Papillomavirus e7 protein
WO2024067725A1 (zh) 一种融合前构象的呼吸道合胞病毒重组融合蛋白、其制备方法及用途
JP2002511847A (ja) Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓに関連した歯周病の診断および治療のための合成ペプチド構築物
JP2004502446A5 (cg-RX-API-DMAC7.html)
JPH0775546B2 (ja) 水痘−帯状疱疹ウイルスにたいするワクチン
JP2005512518A5 (cg-RX-API-DMAC7.html)
JP2025512062A5 (cg-RX-API-DMAC7.html)
JP2004532037A5 (cg-RX-API-DMAC7.html)
TW200716166A (en) Lawsonia intracellularis immunological proteins